AP NEWS
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Global Cardiac Biomarkers Market, Forecast to 2025 - Demand & Growth Dynamics by Type, Application, Testing & Region - ResearchAndMarkets.com

November 27, 2019

DUBLIN--(BUSINESS WIRE)--Nov 27, 2019--

The “Cardiac Biomarkers Market Size, Outlook and Growth Opportunities, 2019- 2025” report has been added to ResearchAndMarkets.com’s offering.

This report includes the latest predictions of the global Cardiac Biomarkers market along with geography, therapy area, and applications. The report specifically focuses on different types of Cardiac Biomarkers with special attention to their emergence over the forecast period to 2025.

The research report provides objective measures to tap into future opportunities that will be available over the next six-years. It also highlights key areas to watch over the future along with detailed insights into drivers and challenges across different Cardiac Biomarkers applications and products.

The Cardiac Biomarkers market report aggregates the current market size based on volume and average price data. It also includes a six-year outlook to 2025 based on anticipated growth rates for each sub-segment and industry as a whole.

The base case outlook in the next six-years for different types of Cardiac Biomarkers, across different verticals and countries, is provided. It additionally examines the key dynamics around companies, markets, along with key trends, drivers and challenges facing the Cardiac Biomarkers worldwide.

The report covers a broad region from the Asia Pacific, North America, Europe, Latin America, and Middle East Africa from 2018 to 2025. 12 countries across these regions are analyzed independently in the Cardiac Biomarkers report. Impact of domestic market conditions, price variations, competition, government policies, healthcare spending, technological and local market conditions are assessed for country-level forecasts.

Global spending on healthcare continues to increase significantly with the aging population, increased access to treatment and ongoing advancements in technology. This provides strong support for Cardiac Biomarkers market growth in the medium to long term future. While growth will remain steady in the developed markets, Asian and other emerging markets will be key for Cardiac Biomarkers market growth from 2019 to 2025.

To address the expanding need for advanced Cardiac Biomarkers products, companies are rapidly embracing the new market dynamics, primarily focusing on new launches, specifically to suit local and regional demand patterns. Accordingly, detailed discussion about broader implications of key strategies, product launches, and other latest Cardiac Biomarkers market developments are included in the research work.

Scope of the Report

This report covers the 2018 market scenario and outlook of Cardiac Biomarkers to 2025. Market size is computed using different types, applications of Cardiac Biomarkers across geographies.

1. Cardiac Biomarkers market size, US$, 2018-2025

2. Cardiac Biomarkers market drivers

3. Cardiac Biomarkers market challenges

4. Cardiac Biomarkers market opportunities

5. Cardiac Biomarkers market trends

6. Cardiac Biomarkers market size forecast by type, 2018-2025

7. Cardiac Biomarkers market size forecast by application, 2018-2025

8. Cardiac Biomarkers market size forecast by country, 2018-2025

9. Cardiac Biomarkers market companies and their strategies

10. Financial and Business Profile of leading vendors

11. Cardiac Biomarkers market news and deals

Key Topics Covered

1. Table of Contents

1.1. List of Tables

1.2. List of Figures

2. A Review of 2018 and Outlook to 2025

2.1. Trend Analysis

2.2. Critical Success Factors

2.3. Demand and Growth Dynamics by Type

2.4. Demand and Growth Dynamics by Application

2.5. Demand and Growth Dynamics by Market

3. Strategic Analysis

3.1. Largest Drivers of Cardiac Biomarkers Market Growth

3.2. Different Challenges Faced by Cardiac Biomarkers Companies

3.3. Five Forces Analysis

4. Cardiac Biomarkers Market, by Type

4.1 Creatine Kinase

4.2 Troponins

4.3 Myoglobin

4.4 Natriuretic peptides

4.5 Ischemia Modified Albumin

4.6 Others

5. Cardiac Biomarkers Market, by Application

5.1 Myocardial Infarction

5.2 Congestive Heart Failure

5.3 Acute Coronary Syndrome

5.4 Atherosclerosis

5.5 Others

6. Cardiac Biomarkers Market, by Testing

6.1 Point of care testing

6.2 Laboratory testing

7. Asia Pacific Cardiac Biomarkers Market Outlook

7.1 Leading Cardiac Biomarkers Types contributing to Asia Pacific market

7.2 Top Applications contributing to Asia Pacific Cardiac Biomarkers

7.3 Top countries contributing to Asia Pacific Cardiac Biomarkers

8. Europe Cardiac Biomarkers Market Outlook

8.1 Leading Cardiac Biomarkers Types contributing to Europe market

8.2 Top Applications contributing to Europe Cardiac Biomarkers

8.3 Top countries contributing to Europe Cardiac Biomarkers

9. North America Cardiac Biomarkers Market Outlook

9.1 Leading Cardiac Biomarkers Types contributing to North America market

9.2 Top Applications contributing to North America Cardiac Biomarkers

9.3 Top countries contributing to North America Cardiac Biomarkers

10 South and Central America Cardiac Biomarkers Market Outlook

10.1 Leading Cardiac Biomarkers Types contributing to South and Central America market

10.2 Top Applications contributing to South and Central America Cardiac Biomarkers

10.3 Top countries contributing to South and Central America Cardiac Biomarkers

11 Middle East Africa Cardiac Biomarkers Market Outlook

11.1 Leading Cardiac Biomarkers Types contributing to Middle East Africa market

11.2 Top Applications contributing to Middle East Africa Cardiac Biomarkers

11.3 Top countries contributing to Middle East Africa Cardiac Biomarkers

12 Company Profile Snapshots

12.1 Top Companies Operating in Cardiac Biomarkers market

12.2 Abbott laboratories Business Profile, SWOT and Financial Analysis

12.3 Alere Inc. Business Profile, SWOT and Financial Analysis

12.4 Beckman Coulter Business Profile, SWOT and Financial Analysis

12.5 Becton, Dickinson And Co. Business Profile, SWOT and Financial Analysis

12.6 BioMerieux Business Profile, SWOT and Financial Analysis

12.7 Bio-Rad Laboratories Business Profile, SWOT and Financial Analysis

12.8 Randox laboratories Business Profile, SWOT and Financial Analysis

12.9 Roche Diagnostics Corporation Business Profile, SWOT and Financial Analysis

12.10 Siemens Healthcare Business Profile, SWOT and Financial Analysis

12.11 Thermo Fisher Scientific Business Profile, SWOT and Financial Analysis

13 Recent Industry Developments

For more information about this report visit https://www.researchandmarkets.com/r/1lyjzv

View source version on businesswire.com:https://www.businesswire.com/news/home/20191127005476/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

KEYWORD:

INDUSTRY KEYWORD: BIOTECHNOLOGY HEALTH CARDIOLOGY

SOURCE: Research and Markets

Copyright Business Wire 2019.

PUB: 11/27/2019 10:34 AM/DISC: 11/27/2019 10:34 AM

http://www.businesswire.com/news/home/20191127005476/en